MYC and familial pancreatic carcinoma: Therefore, we performed the further mechanism study in present study, and the results showed that downregulation of c-Myc enhanced the antitumor activity of bufalin on pancreatic cancer cells by suppressing the HIF-1α/SDF-1/CXCR4 pathway.